immune-checkpoint

Documents about immune-checkpoint

• Dynamics of T Cell Expression of Immune Checkpoint Molecules in Progressive Multifocal Leukoencephalopathy#1009917ClinicalTrials.gov
• Adjuvant Immune Checkpoint Inhibitors in Postoperative Hepatocellular Carcinoma#835507ClinicalTrials.gov
• Real World Pharmacokinetics of Immune Checkpoint Inhibitors#992775ClinicalTrials.gov
• Eculizumab for myasthenic exacerbation during treatment with immune-checkpoint inhibitors#268893IRIS
• PHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to Steroid Exposure#864722ClinicalTrials.gov
• Autoantibodies in Treatment with Immune Checkpoint Inhibitors (AUTENTIC)#994055ClinicalTrials.gov
• Adjuvant Immune Checkpoint Inhibitor Versus Observation After Neoadjuvant Immunochemotherapy and Surgery in High-Risk NSCLC#811484ClinicalTrials.gov
• Chemotherapy With or Without Immune Checkpoint Inhibitors for Lung Cancer#812371ClinicalTrials.gov
• A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor Immunotherapy#448275ClinicalTrials.gov
• Machine learning approaches to predict early cardiac immune-related adverse events in patients receiving immune checkpoint inhibitors#1054557OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Development of an EORTC Immune Checkpoint Inhibitor-specific Quality of Life Item List: Phase 1 & 2#28318ClinicalTrials.gov
• PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer#6810OpenAlex
• Artificial intelligence in immune checkpoint inhibitor research: A bibliometric analysis of the landscape.#412895PubMed
• Correlation of Psychological Distress and Immune Checkpoint Inhibitors in Gastric Cancer#1032878ClinicalTrials.gov
• The blockade of immune checkpoints in cancer immunotherapy#6784OpenAlex
• Baseline D-dimer as a predictor of immune checkpoint inhibitor efficacy in cancer#4693Europe PMC
• Clinical Significance of Hepatic Biomarkers in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors#873179ClinicalTrials.gov
• Upfront Immune Checkpoint Inhibitors With Deferred Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma#902306ClinicalTrials.gov
• Predictive value of baseline eosinophil counts for immune-related adverse events in metastatic NSCLC treated with immune checkpoint inhibitors#386527ARPHA OAI-PMH Endpoint
• Vaccine safety for individuals receiving immune checkpoint inhibitor therapy: A narrative review of current literature and recommendations for future research#4645Europe PMC
• CLEC2B-KLRB1 axis acts as an immune checkpoint, governing the exhaustion of CD8(+) T cells and their resistance to immune checkpoint blockade.#251063NCBI PubMed Central
• Efficacy and Safety of Immune Checkpoint Inhibitors for Refractory Opportunistic Infections in AIDS#912776ClinicalTrials.gov
• Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Treated With Immune Checkpoint Inhibitors#875905ClinicalTrials.gov
• Association Of Immune Checkpoint Inhibitor Approval On Suicide Rates Among Patients With Cancer: A Pre-Post Analysis With Seer#167490EliScholar
• Investigating B Cell Function and Immune Checkpoint Expression in Patients with Chronic Lymphocytic Leukemia.#305924ResearchSpace
• The Risk Factors for Acute Radiation Pneumonitis in Patients With Prior Receipt of Immune Checkpoint Inhibitors#875335ClinicalTrials.gov
• Management of Immune Checkpoint Inhibition-related Hepatitis Using Low-dose Corticosteroids#287546ClinicalTrials.gov
• Mycophenolate Mofetil w/ Prednisone for Immune Related Hepatitis From Checkpoint Inhibitor Therapy#332755ClinicalTrials.gov
• Real-world outcomes of immune checkpoint inhibitors in people with HIV and skin cancer: a multicentre study#294704HAL (France)
• B-Cell involvement in immune checkpoint inhibitor-induced lichen planus: A comparative analysis with non–drug-related lichen planus#471876HAL (France)
• XmAb23104 (PD1 X ICOS) and XmAb22841 (CTLA-4 X LAG3) in Treating Melanoma Prior Immune Checkpoint Inhibitor Therapy#835520ClinicalTrials.gov
• Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature#893644ClinicalTrials.gov
• Gene-level gut microbiome signatures as predictive biomarkers for response to immune checkpoint inhibitors across multiple cancer types.#136108PubMed
• Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer#840354ClinicalTrials.gov
• Pilot Study of Intermittent Fasting With Immune Checkpoint Inhibitors#881858ClinicalTrials.gov
• TNF-Inhibitor as Immune Checkpoint Inhibitor for Advanced MELanoma#201713ClinicalTrials.gov
• Immune Checkpoint Landscape in Pediatric Uveal Melanoma#454621IRIS
• Early Vedolizumab as First-Line for Immune-Related Colitis Therapy Trial#460102ClinicalTrials.gov
• Evaluating Urinary Biomarkers for Early Detection of Kidney Damage in Immune Checkpoint Inhibitors-Treated Patients#291401Gestión del Repositorio Documental de la Universidad de Salamanca
• Immune Checkpoint Inhibitor Associated Cardiovascular Adverse Events in Patients With Cancer#839698ClinicalTrials.gov
• Patients with Cancer and Immune Checkpoint Inhibitor-Induced Rheumatic irAEs Treated by DMARDs: The RHUMICI Single-Centre Retrospective Cohort#922929HAL (France)
• Modulating the gut microbiota to enhance immune checkpoint inhibitor efficacy in colorectal cancer: mechanisms, therapeutic strategies, and clinical perspectives#120190Europe PMC
• Immune checkpoint inhibitor-induced cardiotoxicity: from immune mechanisms to clinical surveillance and targeted therapies.#452937NCBI PubMed Central
• Siglec-15 is a glyco-immune checkpoint in prostate cancer regulating immune evasion and metastasis#668726bioRxiv / medRxiv
• Cancer Nutrition Study - A Study of Dietary Interventions in Cancer Patients Treated With Immune Checkpoint Inhibitors#982591ClinicalTrials.gov
• The efficacy of immune checkpoint inhibitors in metastatic castration-resistant prostate cancer: A meta-analysis and reconstructed individual patient data analysis#4635Europe PMC
• Characterization of Age-Associated, Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammatory Index (SII) as Biomarkers of Inflammation in Geriatric Patients with Cancer Treated with Immune Checkpoint Inhibitors: Impact on Efficacy and Survival#268889IRIS
• Remodeling memory T cells with chemotherapy and immune checkpoint inhibitors as host pre-conditioning to empower in vivo CAR-T therapy#253510Europe PMC
• Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeted Drugs / Locoregional Therapy in the Treatment of Hepatocellular Carcinoma#444870ClinicalTrials.gov
• Ivermectin Combined With Immune Checkpoint Inhibition in Cancer (ICONIC)#208443ClinicalTrials.gov